The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
about
Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysisDesigning liver resections and pushing the envelope with resections for hepatic colorectal metastases'Liver-first' approach for metastatic colorectal cancer.Diffusion-weighted imaging of the liver: techniques and applications.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.The role of peri-operative treatment in resectable liver metastases of colorectal cancer.Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.Current state of surgical treatment of liver metastases from colorectal cancerColorectal liver metastasesAccuracy of [18F]FDG PET/MRI for the Detection of Liver MetastasesHistologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.Disappearing liver metastases from colorectal cancer: impact of modern imaging modalitiesChemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury.The association between preoperative chemotherapy and the prevalence of hepatic steatosis in hepatectomy for metastatic colorectal cancer.Preoperative administration of bevacizumab is safe for patients with colorectal liver metastasesManagement of potentially resectable colorectal cancer liver metastasesA systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastasesIn vivo assessment of intratumoral aspirin injection to treat hepatic tumors.A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis.Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.Predictive markers of colorectal cancer liver metastases.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis.Current opinion on optimal treatment for colorectal cancer.Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.Systemic treatment of liver metastases from colorectal cancer.Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastasesRandomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases.External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer.The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis.ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
P2860
Q26777704-92A08C54-BA25-4CAD-8C0F-4076157F7AFCQ26864128-CB6FE658-B4F5-41B2-A1F7-C34B960391C1Q30373308-25073656-2176-4F69-8E9D-8415C6444C5EQ30840354-468A8F75-5FBE-488E-BDD8-42EDC9F8C0A7Q33977304-344341E2-5C74-472C-BF27-A75A6ED137E9Q35076305-16803034-6AEC-4C1A-A945-8AE60D763F9CQ35171584-05A6A196-E00F-4612-B4E4-7E23C0669249Q35653302-DF6132C8-FD90-4FAD-86CF-36D10C692178Q35687594-558BD67A-A5FC-42A1-BC6A-24DBC27F303BQ35763359-D09C9108-E968-4A45-B205-B20B2D5247FCQ36003241-BB4DA53B-1257-473A-8FDB-A2DCF2CA7392Q36160752-DDCE5F99-B7F1-4629-9D02-3C8599850303Q36343394-4C8CED6A-EF09-4766-88CA-EFFAEF00E882Q36370523-C322EE5A-F1B3-4EF1-924E-32FF6C0ED38CQ36615997-4BED3D11-C098-4268-B77B-3599B6323885Q36871770-C43B1A58-3111-421E-AFEB-EB6936608E8FQ36953786-EE60E485-9929-4D5C-BB96-CF66DCFAA7AFQ37049114-F05C3354-23B7-4A16-A746-9961EC754C83Q37080300-5266DBBB-FCB4-4C53-B5ED-C4E424FFBD98Q37500453-D6A65874-D1C9-4DE5-BD32-82D96FB32590Q37850818-672F7438-C66F-4FD7-AB28-A2538E33146BQ37907117-19B3427E-4720-4511-9C38-BF6326FCB196Q38024277-E4828D90-2E70-4556-BAC1-C626BBF8493FQ38101612-1C71DC58-10DB-4DC4-9557-3C84446C5800Q38191225-D7026EB5-931F-43F8-8121-E22AC8EFA3A1Q38199370-F76F066F-D586-42EE-B6FD-35ADFAC55774Q38348770-8D7E6ECD-E97B-4BCF-A57E-348EC0132473Q38579560-F167835B-CB53-4C2B-933F-45F3D394E836Q39365352-18CB6874-6293-46FF-9572-25D60287E592Q39949794-311F49F7-5A39-4601-B7BE-109C95A2EF32Q41352647-E92C2939-B813-44F1-84F5-49DF08A975EFQ43457248-810374A7-6057-451A-94E5-38F47764E2CAQ45086398-CEFC044E-BACB-4E2D-8C9D-C90E28F972EDQ46170838-44D3A880-F1C0-47BE-8E2C-1CE4DD62285AQ50923685-60D83220-B77B-433B-BA38-DC37338F0881Q51020201-6D702199-E7E2-495B-9D8B-74BE56669A88Q53026533-F23587A7-C455-47C5-B89F-01CAEF88C17DQ53156555-16999AF1-AEAB-4FC3-8B63-1680F31AF438Q57758061-DA8245BF-A026-4289-BA22-06CDC02AEA48
P2860
The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of preoperative chemo ...... e colorectal liver metastases.
@en
The role of preoperative chemo ...... e colorectal liver metastases.
@nl
type
label
The role of preoperative chemo ...... e colorectal liver metastases.
@en
The role of preoperative chemo ...... e colorectal liver metastases.
@nl
prefLabel
The role of preoperative chemo ...... e colorectal liver metastases.
@en
The role of preoperative chemo ...... e colorectal liver metastases.
@nl
P1476
The role of preoperative chemo ...... e colorectal liver metastases.
@en
P2093
Bernard Nordlinger
Stéphane Benoist
P2888
P304
P356
10.1245/S10434-009-0492-7
P577
2009-06-25T00:00:00Z
P6179
1022812524